Cranbrook Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.67M | Sell |
14,566
-117
| -0.8% | -$25.2K | 0.69% | 36 |
|
|
2026
Q1 | $3.19M | Sell |
14,683
-18
| -0.1% | -$3.99K | 0.65% | 37 |
|
|
2025
Q4 | $3.36M | Buy |
14,701
+1,440
| +11% | +$328K | 0.66% | 37 |
|
|
2025
Q3 | $3.07M | Sell |
13,261
-830
| -6% | -$169K | 0.62% | 38 |
|
|
2025
Q2 | $2.62M | Buy |
14,091
+1,619
| +13% | +$301K | 0.56% | 39 |
|
|
2025
Q1 | $2.61M | Sell |
12,472
-83
| -0.7% | -$16.1K | 0.61% | 39 |
|
|
2024
Q4 | $2.23M | Sell |
12,555
-678
| -5% | -$125K | 0.52% | 40 |
|
|
2024
Q3 | $2.61M | Buy |
13,233
+4,885
| +59% | +$912K | 0.6% | 38 |
|
|
2024
Q2 | $1.43M | Buy |
8,348
+4,121
| +97% | +$683K | 0.35% | 46 |
|
|
2024
Q1 | $770K | Hold |
4,227
| – | – | 0.19% | 55 |
|
|
2023
Q4 | $655K | Sell |
4,227
-150
| -3% | -$21.9K | 0.17% | 52 |
|
|
2023
Q3 | $652K | Hold |
4,377
| – | – | 0.19% | 55 |
|
|
2023
Q2 | $590K | Hold |
4,377
| – | – | 0.16% | 59 |
|
|
2023
Q1 | $698K | Hold |
4,377
| – | – | 0.2% | 54 |
|
|
2022
Q4 | $707K | Hold |
4,377
| – | – | 0.19% | 59 |
|
|
2022
Q3 | $587K | Hold |
4,377
| – | – | 0.15% | 65 |
|
|
2022
Q2 | $670K | Hold |
4,377
| – | – | 0.17% | 60 |
|
|
2022
Q1 | $709K | Hold |
4,377
| – | – | 0.15% | 62 |
|
|
2021
Q4 | $593K | Hold |
4,377
| – | – | 0.13% | 69 |
|
|
2021
Q3 | $472K | Buy |
4,377
+77
| +2% | +$8.8K | 0.11% | 77 |
|
|
2021
Q2 | $484K | Sell |
4,300
-132
| -3% | -$14.9K | 0.11% | 73 |
|
|
2021
Q1 | $480K | Buy |
4,432
+1,092
| +33% | +$117K | 0.12% | 70 |
|
|
2020
Q4 | $358K | Hold |
3,340
| – | – | 0.09% | 79 |
|
|
2020
Q3 | $293K | Hold |
3,340
| – | – | 0.08% | 78 |
|
|
2020
Q2 | $328K | Hold |
3,340
| – | – | 0.1% | 75 |
|
|
2020
Q1 | $254K | Hold |
3,340
| – | – | 0.09% | 74 |
|
|
2019
Q4 | $296K | Sell |
3,340
-283
| -8% | -$23.5K | 0.08% | 75 |
|
|
2019
Q3 | $274K | Buy |
3,623
+283
| +8% | +$19.4K | 0.08% | 76 |
|
|
2019
Q2 | $243K | Hold |
3,340
| – | – | 0.07% | 77 |
|
|
2019
Q1 | $269K | Hold |
3,340
| – | – | 0.08% | 72 |
|
|
2018
Q4 | $308K | Buy |
+3,340
| New | +$294K | 0.11% | 62 |
|
Other funds holding ABBV
Cranbrook Wealth Management's ABBV Position: Q2 2026 in Review
Cranbrook Wealth Management reduced its AbbVie (ABBV) stake by 0.8% in Q2 2026, selling an estimated $25.2K and leaving 14,566 shares worth $3.67M. The position accounts for 0.69% of the portfolio, ranked #36.
Cranbrook Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cranbrook Wealth Management held 14,566 shares of AbbVie worth $3.67M as of Q2 2026.
- Cranbrook Wealth Management sold 117 AbbVie shares in Q2 2026, an estimated $25.2K.
- AbbVie made up 0.69% of Cranbrook Wealth Management's portfolio in Q2 2026, its #36 holding.
- Cranbrook Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.